166 related articles for article (PubMed ID: 15212967)
1. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
Bileviciute-Ljungar I; Spetea M
Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
[TBL] [Abstract][Full Text] [Related]
2. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
Bileviciute-Ljungar I; Saxne T; Spetea M
Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
6. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
7. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
9. Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):375-8. PubMed ID: 12235273
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
Charron C; Messier C; Plamondon H
Physiol Behav; 2008 Feb; 93(3):502-11. PubMed ID: 18031772
[TBL] [Abstract][Full Text] [Related]
11. Trial-selective effects of U50,488H, a kappa-opioid receptor agonist, on consummatory successive negative contrast.
Wood MD; Norris JN; Daniel AM; Papini MR
Behav Brain Res; 2008 Nov; 193(1):28-36. PubMed ID: 18514923
[TBL] [Abstract][Full Text] [Related]
12. Anxiety and ethanol consumption in victorious and defeated mice; effect of kappa-opioid receptor activation.
Kudryavtseva N; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM
Eur Neuropsychopharmacol; 2006 Oct; 16(7):504-11. PubMed ID: 16524701
[TBL] [Abstract][Full Text] [Related]
13. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
Wang G; Wang H; Yang Y; Wong TM
Eur J Pharmacol; 2004 Sep; 498(1-3):53-8. PubMed ID: 15363975
[TBL] [Abstract][Full Text] [Related]
14. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
15. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
[TBL] [Abstract][Full Text] [Related]
16. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
Chen BP; Mao HJ; Fan FY; Bruce IC; Xia Q
Scand Cardiovasc J; 2005 Dec; 39(6):375-82. PubMed ID: 16352491
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactam antibiotic prevents tolerance to the hypothermic effect of a kappa opioid receptor agonist.
Rawls SM; Robinson W; Patel S; Baron A
Neuropharmacology; 2008 Oct; 55(5):865-70. PubMed ID: 18644397
[TBL] [Abstract][Full Text] [Related]
18. The individual and combined effects of U50,488, and flurbiprofen axetil on visceral pain in conscious rats.
Kitamura T; Ogawa M; Yamada Y
Anesth Analg; 2009 Jun; 108(6):1964-6. PubMed ID: 19448232
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
20. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.
Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ
Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
